헤르페스 바이러스를 이용한 두경부암의 유전자 치료

참고문헌 (24)

1. "Head andNeck Cancer", 328, pp.184~94 (1993)
2. "Nationalcancer data base report on cancer of the head and neck", 124, pp.951~962 (1998)
3. "The ADA human gene therapyclinical protocol", 1, pp.331~62 (1990)
4. "In vivo molecular therapy withp53 adenovirus for microscopic residual head and neck suqamouscarcinoma", 55, pp.1~6 (1995)
5. "Combinationgene therapy for oral cancer in a murine model", 56, pp.1737~1741 (1996)
6. "Interleukin-12 gene therapy prevents establishment ofSCCVII squamous cell carcinomas, Inhibits tumor growth, and elicitslong-term antitumor immunity in syngeneic C3H mice", 108, pp.261~268 (1998)
7. "Ex vivo gene therapy using cytokine-transducedtumor vaccines: Molecular and clinical pharmacology", pp.661~676 (1998), Sem Oncol
8. "Efficient gene transfer to humn squamous cell carcinoma by theherpes simplex virus type1 amplicon vector", 176, pp.404~408 (1998)
9. "Rapid and efficient gene transfer in human hepatocytes byherpes viral vectors", 22, pp.723~729 (1995)
10. "Oncolytic viral therapy for human colorectal cancerand liver metastases using a multi-mutated herped simplex virus type-1", 13, pp.1325~1334 (1999)
11. "Rapid production of interleukine-2-secreting tumor cells by herpessimplex virus-mediated gene transfer:Implications for autologousvaccine production", 7, pp.2217~2224 (1996)
12. "Immunity to methylcholanthrene induced sarcomas", 18, pp.767~78 (1957)
13. "Combination gene therapy using multiple immunomodulatory genestransferred by a defective infectious single-cycle herpes virus in squamouscell cancer", 7, pp.1279~1285 (2000)
14. "An efficient deletionmutation packaging system for defective herpes simplex virus vectors:Potential applications to human gene therapy and neuronal physiology", 87, pp.8950~4 (1990)
15. "Clinical promise of tumor immunology", 349, pp.19~22 (1997)
16. "Mapping of herpes simplexvirus-1 neurovirulence to gamma 34 a gene nonessential for growthin culture", pp.1262~6
17. "Attenuatedmulti-mutated herpes simplex virus-1 for the treatment of malignantgliomas", 1, pp.938~943 (1995)
18. "Selectiveinfection and cytolysis of human head and neck squamous cell carcinomawith sparing of normal mucosa by a cytotoxic herpes simplexvirus type 1", 10, pp.1599~1606 (1999)
19. "Effectivetreatment of head and neck squamous cell carcinoma by an oncolyticherpes simplex virus", 193, pp.12~21 (2001)
20. "Cytokine gene transfer enhances herpes oncolytic therapy inmurine squamous cell carcinoma", 12, pp.253~265 (2001)
21. "Genotoxic stress confers preferentialand coordinate messenger RNA stability on the five gadd genes", 54, pp.5656~62 (1994)
22. "The carboxylterminus of the murine MyD116 gene substitutes for the correspondingdomain of theγ134 5 gene of herpes simplex virus to preclude thepremature shutoff of total protein synthesis in infected human cells", 70, pp.84~90 (1996)
23. "Expression of ribonucleotide reductase afterionizing radiation in human cervical carcinoma cells", 58, pp.2245~2252 (1998)
24. "Combination of mutated herpes simplex virus type 1 with radiation for the treatment of squamous cell carcinoma of thehead and neck", 41, pp.313~322 (2005)

관련 논문AI추천